These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23089529)

  • 1. Trifecta or triple threat? The challenge of post-PCI management in patients receiving chronic oral anticoagulant therapy.
    Healey JS
    Can J Cardiol; 2013 Feb; 29(2):136-8. PubMed ID: 23089529
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.
    Ho KW; Ivanov J; Freixa X; Overgaard CB; Osten MD; Ing D; Horlick E; Mackie K; Seidelin PH; Džavík V
    Can J Cardiol; 2013 Feb; 29(2):213-8. PubMed ID: 23089528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    Galli M; Andreotti F; D'Amario D; Porto I; Crea F
    J Am Coll Cardiol; 2020 Apr; 75(14):1727-1728. PubMed ID: 32273039
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention/stenting: a systematic review and meta-analysis.
    Andrade JG; Deyell MW; Khoo C; Lee M; Humphries K; Cairns JA
    Can J Cardiol; 2013 Feb; 29(2):204-12. PubMed ID: 23036279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for the reduction of stent thrombosis.
    Yang DC; Swaminathan RV; Kim LK; Feldman DN
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):567-76. PubMed ID: 23621139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.
    Mahmud E; Ramsis M; Behnamfar O; Enright K; Huynh A; Kaushal K; Palakodeti S; Li S; Teh P; Lin F; Reeves R; Patel M; Ang L
    Am J Cardiol; 2016 May; 117(10):1575-1581. PubMed ID: 27040574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents: newer is better!
    Lopes AC; Lemos PA
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1061. PubMed ID: 25418001
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study.
    Otsuki H; Yamaguchi J; Kamishima K; Arashi H; Hagiwara N
    Heart Vessels; 2018 Sep; 33(9):986-996. PubMed ID: 29549436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.
    Adam Z; Turley A; Mason JM; Kasim AS; Newby D; Mills N; Padfield G; Thompson L; Morley R; Hall JA; Wright RA; Muir DF; Sutton AG; Swanson N; Carter J; Bilous R; Jones S; de Belder MA
    Int J Cardiol; 2016 Aug; 216():1-8. PubMed ID: 27135149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination.
    Elewa H; Ahmed D; Barnes GD
    Semin Thromb Hemost; 2016 Sep; 42(6):662-70. PubMed ID: 27235831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
    Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update.
    Capodanno D
    Heart; 2018 Dec; 104(23):1976-1983. PubMed ID: 29695514
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.
    Dzeshka MS; Brown RA; Capodanno D; Lip GY
    Interv Cardiol Clin; 2017 Jan; 6(1):91-117. PubMed ID: 27886825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.